Literature DB >> 22914589

Risk of death among persons with Alzheimer's disease: a national register-based nested case-control study.

Eija Lönnroos1, Pentti Kyyrönen, J Simon Bell, Tischa J M van der Cammen, Sirpa Hartikainen.   

Abstract

Few studies have reported the risk of death related to Alzheimer's disease (AD) in large population-based cohorts. The objective of this study was to analyze the impact of AD on all-cause mortality in a nationwide sample of persons with AD. Community-dwelling persons with AD and an equal number of individually matched (age, gender, and region of residence) control persons without AD were identified from the registers of Social Insurance Institution of Finland at the end of 2005. Deaths in this sample (n = 56,041, mean age 79.7 years, 67.8% women) during a 57-month follow-up period were recorded. Using a nested case-control design, unadjusted and adjusted (cardiovascular disease, cancer, diabetes, and asthma and/or COPD) hazard ratios (HR) with 95% confidence intervals (CI) were computed using proportional hazards regression. The results were categorized according to age at death (<80, 80 to 89, ≥ 90 years) and duration of AD (≤ 3, 4 to 6, ≥ 7 years). The unadjusted HR for death associated with AD was 2.03 (95% CI: 1.97 to 2.09). The HR was highest in the youngest age category [HR = 3.46 (95% CI: 3.18 to 3.77)], and still significantly elevated in the oldest age category [HR = 1.50 (95% CI: 1.41 to 1.60)]. Comorbidity adjustments did not change the HRs, and even a short duration of AD (≤ 3 years) was associated with a significantly increased risk of death. In conclusion, AD was associated with an increased risk of death that was more pronounced at younger ages and existed even after a recent diagnosis of AD.

Entities:  

Mesh:

Year:  2013        PMID: 22914589     DOI: 10.3233/JAD-2012-120808

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  11 in total

1.  Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study.

Authors:  Stephanie Jb Vos; Chengjie Xiong; Pieter Jelle Visser; Mateusz S Jasielec; Jason Hassenstab; Elizabeth A Grant; Nigel J Cairns; John C Morris; David M Holtzman; Anne M Fagan
Journal:  Lancet Neurol       Date:  2013-09-04       Impact factor: 44.182

2.  Coronary Revascularization and Postoperative Outcomes in People With and Without Alzheimer's Disease.

Authors:  Mai Vu; Marjaana Koponen; Heidi Taipale; Raimo Kettunen; Sirpa Hartikainen; Anna-Maija Tolppanen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-07-13       Impact factor: 6.053

3.  Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) study.

Authors:  Anna-Maija Tolppanen; Heidi Taipale; Marjaana Koponen; Piia Lavikainen; Antti Tanskanen; Jari Tiihonen; Sirpa Hartikainen
Journal:  Clin Epidemiol       Date:  2013-08-07       Impact factor: 4.790

4.  Impact of high risk drug use on hospitalization and mortality in older people with and without Alzheimer's disease: a national population cohort study.

Authors:  Danijela Gnjidic; Sarah N Hilmer; Sirpa Hartikainen; Anna-Maija Tolppanen; Heidi Taipale; Marjaana Koponen; J Simon Bell
Journal:  PLoS One       Date:  2014-01-13       Impact factor: 3.240

5.  Cerebral inflammation is an underlying mechanism of early death in Alzheimer's disease: a 13-year cause-specific multivariate mortality study.

Authors:  Katarina Nägga; Carina Wattmo; Yi Zhang; Lars-Olof Wahlund; Sebastian Palmqvist
Journal:  Alzheimers Res Ther       Date:  2014-07-07       Impact factor: 6.982

6.  Prognosis of patients with dementia: results from a prospective nationwide registry linkage study in the Netherlands.

Authors:  Irene E van de Vorst; Ilonca Vaartjes; Mirjam I Geerlings; Michael L Bots; Huiberdina L Koek
Journal:  BMJ Open       Date:  2015-10-28       Impact factor: 2.692

7.  Risk of Developing Dementia at Older Ages in the United States.

Authors:  Ezra Fishman
Journal:  Demography       Date:  2017-10

8.  Causes of death in a nationwide cohort of community-dwellers with Alzheimer's disease.

Authors:  Anna-Maija Tolppanen; Heidi Taipale; Marjaana Koponen; Jari Tiihonen; Sirpa Hartikainen
Journal:  BMC Geriatr       Date:  2020-11-02       Impact factor: 3.921

9.  The effect of comorbidities on survival in persons with Alzheimer's disease: a matched cohort study.

Authors:  Blair Rajamaki; Sirpa Hartikainen; Anna-Maija Tolppanen
Journal:  BMC Geriatr       Date:  2021-03-09       Impact factor: 3.921

Review 10.  The Impact of Disease Registries on Advancing Knowledge and Understanding of Dementia Globally.

Authors:  Shimaa A Heikal; Mohamed Salama; Yuliya Richard; Ahmed A Moustafa; Brian Lawlor
Journal:  Front Aging Neurosci       Date:  2022-02-07       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.